Agger Mette Kirstine

CIK 00017222344 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001722234

Recent Transactions

27 trades

Award
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2026-06-25+35,000→ 35,000 total
Disposition to Issuer
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-10-07−19,750→ 0 total
Disposition to Issuer
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-10-07−30,000→ 0 total
Award
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2025-06-26+25,000→ 25,000 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-06-03+30,000→ 30,000 total
Award
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2024-06-25+18,000→ 18,000 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2024-06-11+19,750→ 19,750 total
Award
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2024-02-02+36,000→ 36,000 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2023-06-06+17,300→ 17,300 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2020-06-09+6,124→ 6,124 total
Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2020-03-16+1,245,222→ 1,245,222 total
Conversion
Enliven Therapeutics, Inc.$ELVN
Series Seed Preferred Stock
2020-03-16−478,749→ 0 total
Purchase
Enliven Therapeutics, Inc.$ELVN
Common Stock
2020-03-16$16.00/sh+187,500→ 1,432,722 total
Conversion
Enliven Therapeutics, Inc.$ELVN
Series B Preferred Stock
2020-03-16−1,894,444→ 0 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2020-03-16+15,457→ 15,457 total
Conversion
Enliven Therapeutics, Inc.$ELVN
Series A Preferred Stock
2020-03-16−5,470,492→ 0 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2019-06-18+6,124→ 6,124 total
Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2019-05-09+776,544→ 776,544 total
Conversion
Trevi Therapeutics, Inc.$TRVI
Series C Preferred Stock
2019-05-09−6,849,315→ 0 total
Purchase
Trevi Therapeutics, Inc.$TRVI
Common Stock
2019-05-09$10.00/sh+375,000→ 1,151,544 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2019-05-07+23,684→ 23,684 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2018-06-19+6,124→ 6,124 total
Conversion
scPharmaceuticals Inc.$SCPH
Common Stock
2017-11-21+984,366→ 2,529,224 total
Conversion
scPharmaceuticals Inc.$SCPH
Series B Preferred Stock
2017-11-21−7,067,945→ 0 total
Conversion
scPharmaceuticals Inc.$SCPH
Common Stock
2017-11-21+1,544,858→ 1,544,858 total
Conversion
scPharmaceuticals Inc.$SCPH
Series A Preferred Stock
2017-11-21−11,092,383→ 0 total
Purchase
scPharmaceuticals Inc.$SCPH
Common Stock
2017-11-21$14.00/sh+654,762→ 3,183,986 total

Companies

Recent Filings

Address

C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, FLOOR 6

NEW YORK, NY, 10010

View on SEC.gov